Written answers
Wednesday, 22 May 2024
Department of Health
Medicinal Products
Pádraig O'Sullivan (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
158. To ask the Minister for Health if he will provide specific information on the current status of the pricing and reimbursement application for dostarlimab (jemperli) indicated as monotherapy for the treatment of adult patients with recurrent or advanced endometrial cancer; and if he will make a statement on the matter. [23054/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments